NASDAQ:KRBP
Kiromic BioPharma, Inc.
- Stock
Last Close
3.08
17/05 16:41
Market Cap
1.89M
Beta: 0.16
Volume Today
11.56K
Avg: 281.88K
PE Ratio
−0.08
PFCF: −0.10
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -3.82M - | -3.73M 2.30% | -19.20M 415.04% | -25.59M 33.27% | -34.73M 35.73% | -20.95M 39.68% | |
depreciation and amortization | 80.90K - | 87.50K 8.16% | 200K 128.57% | 469.80K 134.90% | 1.67M 256.19% | 2.22M 32.73% | |
deferred income tax | 22.20K - | 5.03M - | |||||
stock based compensation | 633K - | 522.90K 17.39% | 13.25M 2,433.12% | 3.76M 71.59% | 1.24M 67.12% | 141.30K 88.58% | |
change in working capital | 315.80K - | 183.10K 42.02% | -394.50K 315.46% | 710.30K 280.05% | 4.37M 515.22% | -3.21M 173.53% | |
accounts receivables | -78.80K - | 9.80K - | 16.20K 65.31% | ||||
inventory | -5.90K - | ||||||
accounts payables | -4.40K - | 293.40K 6,768.18% | -7.70K 102.62% | 1.41M 18,425.97% | 3.79M 168.64% | -5.03M 232.81% | |
other working capital | 320.20K - | -25.60K 108.00% | -386.80K 1,410.94% | -710.60K 83.71% | 562.90K 179.21% | 5.03M 794.42% | |
other non cash items | 633.10K - | 20.50K 96.76% | 200 99.02% | 324.20K 162,000% | 3.70M 1,042.72% | -4.46M 220.38% | |
net cash provided by operating activities | -2.15M - | -2.91M 35.35% | -6.13M 110.25% | -20.32M 231.69% | -23.75M 16.85% | -21.23M 10.61% | |
investments in property plant and equipment | -137.30K - | -302.70K 120.47% | -1.46M 381.53% | -1.89M 29.99% | -4.88M 157.57% | -206.60K 95.77% | |
acquisitions net | 84K - | ||||||
purchases of investments | |||||||
sales maturities of investments | |||||||
other investing activites | 15K - | ||||||
net cash used for investing activites | -137.30K - | -302.70K 120.47% | -1.46M 381.53% | -1.81M 24.23% | -4.87M 168.69% | -206.60K 95.75% | |
debt repayment | -188.10K - | -573.70K 205.00% | -508K 11.45% | -557.20K 9.69% | |||
common stock issued | 15M - | 40M 166.67% | 659.10K - | ||||
common stock repurchased | |||||||
dividends paid | |||||||
other financing activites | 1.63M - | 993.70K - | -2.09M 310.39% | 4.41M 310.98% | 23.89M 441.61% | ||
net cash used provided by financing activities | 1.63M - | 4.76M 193.01% | 15.81M 231.95% | 37.34M 136.22% | 3.90M 89.55% | 23.99M 514.72% | |
effect of forex changes on cash | |||||||
net change in cash | -665.20K - | 1.54M 332.23% | 8.22M 432.20% | 15.20M 84.92% | -24.71M 262.52% | 2.56M 110.36% | |
cash at beginning of period | 1.05M - | 384.30K 63.38% | 1.93M 401.98% | 10.15M 426.18% | 25.35M 149.78% | 645.20K 97.46% | |
cash at end of period | 384.30K - | 1.93M 401.98% | 10.15M 426.18% | 25.35M 149.78% | 645.20K 97.46% | 3.20M 396.59% | |
operating cash flow | -2.15M - | -2.91M 35.35% | -6.13M 110.25% | -20.32M 231.69% | -23.75M 16.85% | -21.23M 10.61% | |
capital expenditure | -137.30K - | -302.70K 120.47% | -1.46M 381.53% | -1.89M 29.99% | -4.88M 157.57% | -206.60K 95.77% | |
free cash flow | -2.29M - | -3.22M 40.45% | -7.58M 135.78% | -22.22M 192.93% | -28.63M 28.85% | -21.43M 25.13% |
All numbers in USD (except ratios and percentages)